Hero

Proteros biostructures GmbH

Main Industry
Research & Development
updated 
updated 

Key Facts

This company profile is a search result of implisense.com

Products and Services

ScreeningCompoundsSoftware

Size (Revenue & Employees)

Medium-sized company

Balance sheet total

30 M €

Purpose

Biotechnologische Forschung zur Entwicklung neuer Wirkstoffe (drug discovery) und funktional optimierter Proteine (ohne Eintritt in klinische Forschung); Produktion, Marketing und Vertrieb von Produkten und Erbringung sonstiger Dienstleistungen, die zur Entwicklung neuer Wirkstoffe und funktional optimierter Proteine eingesetzt werden (ohne Eintritt in klinische Forschung).

More? Implisense Plus!

Order Implisense Plus now for full company profiles and complete functionality! You will then have access to our GDPR-compliant real-time contact search, full annual reports, all search filters, complete search results and integrated AI analyses of the business model and management report.

  • Real-time search for contact persons
  • Complete annual reports
  • More search filters and results
Order now

Customer Relationship Intelligence: The Key to Optimizing your Sales Processes

Use our AI-powered assistants to identify the right companies, track current developments and market changes, reach relevant decision-makers and perfect your sales strategy with data-based insights. All seamlessly integrated into your CRM.

  • Find the right companies
  • Keep an eye on your target companies
  • Reach the right decision-makers
  • Increase your closing rate

Executive Summary

Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!

Implisense Plus
implisense assist

profile random user logo

implisense assist

Contacts

  • Peter Persigehl
  • Torsten Reinhard Neuefeind

Timeline

Register Announcements

Wesentliche Steigerung der Eigenkapitalquote bei der Proteros biostructures GmbH 2023!

Die Eigenkapitalquote der Proteros biostructures GmbH hat sich um % im Vorjahresvergleich bemerkenswert erhöht, was eine Erhöhung der finanziellen Unabhängigkeit nahe legt. Der neueste Jahresabschluss für das Jahr 2023 ist ab sofort verfügbar und bietet detaillierte Einblicke in die finanzielle Entwicklung des Unternehmens.

Veränderung im Handelsregister

Die Gesellschafterversammlung vom 09.06.2022 hat die Änderung der Ziff. 5 (Gesellschafterversammlung), 6 (Gesellschafterbeschlüsse), 7 (Vertretung, Geschäftsführung), 8 (Beirat; vormals Aufsichtsrat), 9 (Verfügungen über Geschäftsanteile, Vorkaufsrechte, Verkaufspflichten (Drag Along) und Verkaufsrechte (Tag Along)) der Satzung beschlossen.

Abschluss des Förderprojektes "Verbundprojekt: Eine neuartige Plattform zur Wirkstoffsuche als Durchbruch in der Entwicklung von Medikamenten gegen Krebsstammzellen, Teilprojekt: Erstellung einer Screening- und Kristallographie-Plattform zur Entwicklung von Medikamenten gegen Krebsstammzellen" (BMBF 01QE1548)

Heute endet das Förderprojekt "Verbundprojekt: Eine neuartige Plattform zur Wirkstoffsuche als Durchbruch in der Entwicklung von Medikamenten gegen Krebsstammzellen, Teilprojekt: Erstellung einer Screening- und Kristallographie-Plattform zur Entwicklung von Medikamenten gegen Krebsstammzellen". Es wurde vom BMBF unter dem Förderkennzeichen 01QE1548 für die Proteros biostructures GmbH mit einer Summe von 147.873,00 Euro gefördert. Die Laufzeit des Projektes betrug 35 Monate.

Beginn des Förderprojektes "Verbundprojekt: Eine neuartige Plattform zur Wirkstoffsuche als Durchbruch in der Entwicklung von Medikamenten gegen Krebsstammzellen, Teilprojekt: Erstellung einer Screening- und Kristallographie-Plattform zur Entwicklung von Medikamenten gegen Krebsstammzellen" (BMBF 01QE1548)

Heute startet das Förderprojekt "Verbundprojekt: Eine neuartige Plattform zur Wirkstoffsuche als Durchbruch in der Entwicklung von Medikamenten gegen Krebsstammzellen, Teilprojekt: Erstellung einer Screening- und Kristallographie-Plattform zur Entwicklung von Medikamenten gegen Krebsstammzellen". Es wird vom BMBF unter dem Förderkennzeichen 01QE1548 für die Proteros biostructures GmbH mit einer Summe von 147.873,00 Euro gefördert. Die Laufzeit des Projektes beträgt 35 Monate.

Abschluss des Förderprojektes "Spitzencluster m4, Verbund Neuartige Therapeutika: Spitzencluster - Strukturbasierte Antikörpercharakterisierung (T17b)" (BMBF 16EX1022L)

Heute endet das Förderprojekt "Spitzencluster m4, Verbund Neuartige Therapeutika: Spitzencluster - Strukturbasierte Antikörpercharakterisierung (T17b)". Es wurde vom BMBF unter dem Förderkennzeichen 16EX1022L für die Proteros biostructures GmbH mit einer Summe von 449.496,00 Euro gefördert. Die Laufzeit des Projektes betrug 57 Monate.
Latest News

Search in real time for news and events – topic-specific, live, and contextual to the selected company.

Network

Discover connections between companies via managers, shareholdings, links or addresses here.

Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.

Show more

Products & Technologies

Screening
Compounds
Software
Drug Discovery
Entwicklung
Tests
Engineering
Biotechnologie
Chemie
See all 20 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

Show more

Proteros biostructures GmbH is mentioned in public sources in the context of the following products and services. Screening, Compounds and Software are the most common. The ranking list shown is without guarantee of completeness or correctness.

Artificial IntelligenceKünstliche Intelligenz
Communication Standards4. Generation (LTE)
ERPCOVALENT

The following software solutions, technologies and concepts are often referenced in job postings and press releases of Proteros biostructures GmbH. Most frequently recognized were COVALENT, Künstliche Intelligenz and 4. Generation (LTE).

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness

Dominance, Competence, Clarity

Innovation, Passion, Creativity

Harmony, Reliability, Communicatibility

Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. Proteros biostructures GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

Information for Job Seekers

Based on job advertisements of Proteros biostructures GmbH, the following specific requirements for job seekers were identified more frequently. Specific requirements can be found in the latest published job advertisements.

Methodische Kompetenz

  • Zielorientierung

Persönliche Kompetenz

  • Einsatzbereitschaft
  • Flexibilität
  • Beharrlichkeit
  • Motivation

The following additional requirements were identified more frequently. These may vary and are provided for guidance.

  • Sprachkenntnisse

The following benefits were repeatedly recognized in job postings of Proteros biostructures GmbH. This data is supplied without liability and intended for orientation purposes only.

TeamkulturOffene Unternehmenskultur
Register for free and try Implisense Plus!

Register quickly and easily for a free Implisense account. Registered users have access to extended company profiles and receive more comprehensive search results. If you register with a business email address, we will also set up a free 7-day trial for Implisense Plus in a timely manner.

  • Richer Company Profiles
  • Expanded Search Results
  • Personal Favourites
The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all